JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB106590

Anti-NMDAR2A (phospho Y1325) antibody

3

(1 Review)

|

(5 Publications)

Rabbit Polyclonal NMDAR2A phospho Y1325 antibody. Suitable for WB and reacts with Rat, Mouse samples. Cited in 5 publications. Immunogen corresponding to Synthetic Peptide within Human GRIN2A pY1325.

View Alternative Names

NMDAR2A, GRIN2A, GluN2A, Glutamate [NMDA] receptor subunit epsilon-1, N-methyl D-aspartate receptor subtype 2A, NR2A, hNR2A

1 Images
Western blot - Anti-NMDAR2A (phospho Y1325) antibody (AB106590)
  • WB

AbReview29528****

Western blot - Anti-NMDAR2A (phospho Y1325) antibody (AB106590)

All lanes:

Western blot - Anti-NMDAR2A (phospho Y1325) antibody (ab106590) at 1/500 dilution

All lanes:

Rat brain whole tissue lysate at 20 µg

Secondary

All lanes:

HRP Goat anti-rabbit IgG polyclonal at 1/2000 dilution

Predicted band size: 165 kDa

Observed band size: 180 kDa

true

Exposure time: 1min

This image is courtesy of an Abreview submitted by Dr Xiaofan Wang

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Rat, Mouse

Applications

WB

applications

Immunogen

Synthetic Peptide within Human GRIN2A pY1325. The exact immunogen used to generate this antibody is proprietary information.

Q12879

Specificity

Specific for the ~180k NMDAR2A protein phosphorylated at Tyr1325 in Western blots. Immunolabelling is completely blocked by preadsorption with the phosphopeptide but not by the corresponding dephosphopeptide.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Mouse": { "WB-species-checked": "guaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>" }, "Rat": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>" }, "Cow": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" }, "Dog": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Purification notes
Prepared from rabbit serum by affinity purification via sequential chromatography on phospho- and dephospho-peptide affinity columns.
Storage buffer
pH: 7.5 Constituents: 50% Glycerol (glycerin, glycerine), 0.87% Sodium chloride, 0.238% HEPES, 0.01% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

NMDAR2A also known as GRIN2A is a subunit of the N-methyl-D-aspartate (NMDA) receptor which belongs to the family of ionotropic glutamate receptors. This receptor functions as a ligand-gated ion channel and requires both glutamate and glycine for activation. NMDAR2A has a molecular mass of about 164 kDa. It plays a significant role in synaptic transmission and plasticity and is mainly expressed in the brain particularly in the cerebral cortex and hippocampus. Its expression is important for normal brain function affecting learning and memory.
Biological function summary

NMDAR2A participates in synaptic signaling by forming part of the NMDA receptor complex. As part of this complex NMDAR2A interacts with other receptor subunits such as NR1 and NR2B which together modulate calcium influx into the neuron. This influx is essential for activating downstream signaling pathways that influence synaptic strength. The receptor's activation is tightly regulated which helps to maintain the balance between synaptic excitation and inhibition in the central nervous system.

Pathways

NMDAR2A serves essential roles in the long-term potentiation (LTP) and synaptic plasticity pathways. LTP is a process that strengthens synaptic connections and is important for memory formation. NMDAR2A interacts with proteins like postsynaptic density protein 95 (PSD-95) within these pathways to mediate downstream signaling events. It is also involved in the MAPK/ERK pathway affecting cellular processes such as gene expression differentiation and survival.

NMDAR2A has been associated with epilepsy and schizophrenia. Mutations or altered expression of NMDAR2A can disrupt normal receptor function and contribute to these conditions. It shows links with other proteins such as NR2B where imbalances between different NMDA receptor subunits may exacerbate disease pathology. Understanding how NMDAR2A functions and misfunctions helps in investigating therapeutic targets for these neurological diseases.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Component of N-methyl-D-aspartate (NMDA) receptors (NMDARs) that function as heterotetrameric, ligand-gated cation channels with high calcium permeability and voltage-dependent block by Mg(2+) (PubMed : 20890276, PubMed : 23933818, PubMed : 23933819, PubMed : 23933820, PubMed : 24504326, PubMed : 26875626, PubMed : 26919761, PubMed : 28242877, PubMed : 36117210, PubMed : 38538865, PubMed : 8768735). NMDARs participate in synaptic plasticity for learning and memory formation by contributing to the slow phase of excitatory postsynaptic current, long-term synaptic potentiation, and learning (By similarity). Channel activation requires binding of the neurotransmitter L-glutamate to the GluN2 subunit, glycine or D-serine binding to the GluN1 subunit, plus membrane depolarization to eliminate channel inhibition by Mg(2+) (PubMed : 23933818, PubMed : 23933819, PubMed : 23933820, PubMed : 24504326, PubMed : 26875626, PubMed : 26919761, PubMed : 27288002, PubMed : 28095420, PubMed : 28105280, PubMed : 28126851, PubMed : 28182669, PubMed : 29644724, PubMed : 38307912, PubMed : 8768735). NMDARs mediate simultaneously the potassium efflux and the influx of calcium and sodium (By similarity). Each GluN2 subunit confers differential attributes to channel properties, including activation, deactivation and desensitization kinetics, pH sensitivity, Ca2(+) permeability, and binding to allosteric modulators (PubMed : 26875626, PubMed : 26919761). Participates in the synaptic plasticity regulation through activation by the L-glutamate releaseed by BEST1, into the synaptic cleft, upon F2R/PAR-1 activation in astrocyte (By similarity).
See full target information GRIN2A pY1325

Publications (5)

Recent publications for all applications. Explore the full list and refine your search

Research (Washington, D.C.) 7:0482 PubMed39301264

2024

Gut Microbiota-Metabolite-Brain Axis Reconstitution Reverses Sevoflurane-Induced Social and Synaptic Deficits in Neonatal Mice.

Applications

Unspecified application

Species

Unspecified reactive species

Youyi Zhao,Sanxing Ma,Lirong Liang,Shuhui Cao,Ze Fan,Danyi He,Xiaotong Shi,Yao Zhang,Bing Liu,Meiting Zhai,Shengxi Wu,Fang Kuang,Hui Zhang

Frontiers in neuroscience 15:703044 PubMed34658758

2021

GluN2A/ERK/CREB Signaling Pathway Involved in Electroacupuncture Regulating Hypothalamic-Pituitary-Adrenal Axis Hyperactivity.

Applications

Unspecified application

Species

Unspecified reactive species

Yu Wang,Jing Han,Jing Zhu,Mizhen Zhang,Minda Ju,Yueshan Du,Zhanzhuang Tian

Scientific reports 11:3736 PubMed33580102

2021

High levels of 27-hydroxycholesterol results in synaptic plasticity alterations in the hippocampus.

Applications

Unspecified application

Species

Unspecified reactive species

Raul Loera-Valencia,Erika Vazquez-Juarez,Alberto Muñoz,Gorka Gerenu,Marta Gómez-Galán,Maria Lindskog,Javier DeFelipe,Angel Cedazo-Minguez,Paula Merino-Serrais

European neuropsychopharmacology : the journal of 26:1989-1999 PubMed27765467

2016

Glutamatergic neurotransmission in the prefrontal cortex mediates the suppressive effect of intra-prelimbic cortical infusion of BDNF on cocaine-seeking.

Applications

Unspecified application

Species

Unspecified reactive species

Bok Soon Go,Sarah M Barry,Jacqueline F McGinty

The EMBO journal 28:3717-29 PubMed19834457

2009

Involvement of NMDAR2A tyrosine phosphorylation in depression-related behaviour.

Applications

Unspecified application

Species

Unspecified reactive species

Sachiko Taniguchi,Takanobu Nakazawa,Asami Tanimura,Yuji Kiyama,Tohru Tezuka,Ayako M Watabe,Norikazu Katayama,Kazumasa Yokoyama,Takeshi Inoue,Hiroko Izumi-Nakaseko,Shigeru Kakuta,Katsuko Sudo,Yoichiro Iwakura,Hisashi Umemori,Takafumi Inoue,Niall P Murphy,Kouichi Hashimoto,Masanobu Kano,Toshiya Manabe,Tadashi Yamamoto
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com